Katherine Young

Platensimycin is a selective FabF inhibitor with potent antibiotic properties

Jun Wang, S.M. Soisson, Katherine Young et al. · Nature · 2006 · 815 citations

Pharmacy, Medicinal Chemistry, Pharmacology +9

Outbreak of <i>Klebsiella pneumoniae</i> Producing a New Carbapenem-Hydrolyzing Class A β-Lactamase, KPC-3, in a New York Medical Center

Neil Woodford, Philip M. Tierno, Katherine Young et al. · Antimicrobial Agents and Chemotherapy · 2004 · 446 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections

J. Motsch, Cláudia Murta de Oliveira, V.P. Stus et al. · Clinical Infectious Diseases · 2019 · 404 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Discovery of platencin, a dual FabF and FabH inhibitor with <i>in vivo</i> antibiotic properties

Jun Wang, Srinivas Kodali, Sang Ho Lee et al. · Proceedings of the National Academy of Sciences · 2007 · 380 citations · Full text

Life Sciences, Microbiology, Pharmacology +14

Isolation, Structure, and Absolute Stereochemistry of Platensimycin, A Broad Spectrum Antibiotic Discovered Using an Antisense Differential Sensitivity Strategy

Sheo B. Singh, Hiranthi Jayasuriya, John G. Ondeyka et al. · Journal of the American Chemical Society · 2006 · 231 citations

Life Sciences, Biochemistry, Microbiology +13